Atossa Therapeutics (ATOS) Competitor Comparison
We are evaluating the key criteria listed to compare Atossa Therapeutics (ATOS) against its competitors in the Biotechnology industry.
Market Capitalization
249 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
110 / 337Free Cashflow
96 / 352Quick Ratio
15 / 357Earnings per Share
57 / 359Dividend yield
0 / 6Total Cash
220 / 358Performance 3 years
152 / 368Performance 5 years
131 / 368Performance 10 years
335 / 368Linearity 3 years
109 / 368Linearity 5 years
17 / 368Linearity 10 years
288 / 368Total Rank
189 / 368Dividend Rank
367 / 368Valuation Rank
275 / 368Piotroski Rank
328 / 368Muliplier Rank
21 / 368EBITDA - ATOS ranking 110 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.